SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron

Omicron, the most recent SARS-CoV-2 variant of concern (VOC), harbours multiple mutations in the spike protein that were not observed in previous VOCs. Initial studies suggest Omicron to substantially reduce the neutralizing capability of antibodies induced from vaccines and previous infection. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Syed Faraz, Quadeer, Ahmed Abdul, McKay, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781795/
https://www.ncbi.nlm.nih.gov/pubmed/35062283
http://dx.doi.org/10.3390/v14010079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8781795/
https://www.ncbi.nlm.nih.gov/pubmed/35062283
http://dx.doi.org/10.3390/v14010079

Ejemplares similares